Skip Nav Destination
Issues
1 March 2018
ISSN 0003-9985
eISSN 1543-2165
LETTERS TO THE EDITOR
SPECIAL SECTION-UPDATES FROM THE 2016 MOLECULAR CYTOPATHOLOGY MEETING (NAPOLI, ITALY), PART I
CAP LABORATORY IMPROVEMENT PROGRAMS
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, ...
Neal I. Lindeman, MD; Philip T. Cagle, MD; Dara L. Aisner, MD, PhD; Maria E. Arcila, MD; Mary Beth Beasley, MD; Eric H Bernicker, MD; Carol Colasacco, MLIS, SCT(ASCP); Sanja Dacic, MD, PhD; Fred R. Hirsch, MD, PhD; Keith Kerr, MB, ChB; David J. Kwiatkowski, MD, PhD; Marc Ladanyi, MD; Jan A. Nowak, MD, PhD; Lynette Sholl, MD; Robyn Temple-Smolkin, PhD; Benjamin Solomon, MBBS, PhD; Lesley H Souter, PhD; Erik Thunnissen, MD, PhD; Ming S. Tsao, MD; Christina B. Ventura, MPH, MT(ASCP); Murry W Wynes, PhD; Yasushi Yatabe, MD, PhD
Original Articles
Validation of a Cytotechnologist Manual Counting Service for the Ki67 Index in Neuroendocrine Tumors of the Pancreas and Gastrointestinal Tract
Jennielee Cottenden, MD; Emily R. Filter, MD, FRCPC; Jon Cottreau, MD; David Moore, MMedSc; Martin Bullock, MD, FRCPC; Weei-Yuarn Huang, PhD, MD, FRCPC; Thomas Arnason, MD, FRCPC
SPECIAL ARTICLE
Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society
Erik Thunnissen, MD; Timothy Craig Allen, MD, JD; Julien Adam, MD; Dara L. Aisner, MD; Mary Beth Beasley, MD; Alain C. Borczuk, MD; Philip T. Cagle, MD; Vera Luiza Capelozzi, MD, PhD; Wendy Cooper, MD; Lida P. Hariri, MD, PhD; Izidor Kern, MD; Sylvie Lantuejoul, MD, PhD; Ross Miller, MD; Mari Mino-Kenudson, MD; Teodora Radonic, MD, PhD; Kirtee Raparia, MD; Natasha Rekhtman, MD, PhD; Sinchita Roy-Chowdhuri, MD, PhD; Prudence Russell, MBBS(Hons), FRCPA; Frank Schneider, MD; Lynette M. Sholl, MD; Ming Sound Tsao, MD; Marina Vivero, MD; Yasushi Yatabe, MD, PhD
RESIDENT SHORT REVIEW
-
Cover Image
Cover Image
Sponsored Video
Recommendations for Performance Evaluation of Machine Learning in Pathology: A Concept Paper From the College of American Pathologists
Matthew G. Hanna, MD, Niels H. Olson, MD, Mark Zarella, PhD, Rajesh C. Dash, MD, Markus D. Herrmann, MD, PhD, Larissa V. Furtado, MD, Michelle N. Stram, MD, Patricia M. Raciti, MD, Lewis Hassell, MD, Alex Mays, MD, Liron Pantanowitz, MD, PhD, MHA, Joseph S. Sirintrapun, MD, Savitri Krishnamurthy, MD, Anil Parwani, MD, PhD, MBA, Giovanni Lujan, MD, Andrew Evans, MD, Eric F. Glassy, MD, Marilyn M. Bui, MD, PhD, Rajendra Singh, MD, Rhona J. Souers, MS, Monica E. de Baca, MD, Jansen N. Seheult, MD
International Council for Standardization in Haematology Field Study Evaluating Optimal Interpretation Methods for Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies
Robert C. Gosselin, CLS, Gary W. Moore, BSc, DBMS, Geoffrey W. Kershaw, FAIMS, Silmara Montalvão, PhD, Dorothy M. Adcock, MD
Real-World Evidence of Intra-institutional Performance Variation in Indefinite Diagnosis of Pleural Effusion Cytology
Kuang-Hua Chen, MD, Chien-Yi Kuo, MS, Tai-Di Chen, MD
Recent Advances in Genitourinary Tumors Updates From the 5th Edition of the World Health Organization Blue Book Series
Nicole Riddle, MD, MSHI, Vinita Parkash, MBBS, MPH, Charles C. Guo, MD, Steven S. Shen, MD, Sudhir Perincheri, PhD, MBBS, Angela Sanguino Ramirez, MD, MPH, Aaron Auerbach, MD, MPH, Deborah Belchis, MD, Peter Humphrey, MD, PhD
Adenocarcinomas of the Gynecologic Tract Involving the Urinary Bladder: A Series of 16 Cases Potentially Mimicking Urothelial Malignancy
Daniel H. Russell, MD, Jonathan I. Epstein, MD, Oleksandr N. Kryvenko, MD, Matthew Schlumbrecht, MD, MPH, Merce Jorda, MD, PhD, MBA, Andre Pinto, MD
Clinicopathologic Features of Breast Carcinoma With 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0) Breast Cancers
Diane Wilcock, MS, Deepika Sirohi, MD, Daniel Albertson, MD, Allison S. Cleary, MD, PhD, Joshua F. Coleman, MD, Jolanta Jedrzkiewicz, MD, Jonathan Mahlow, MD, Ana L. Ruano, MD, H. Evin Gulbahce, MD, MSCI
Evaluation of the Accuracy of a Polymerase Chain Reaction–Based Assay for Polymerase Epsilon Mutation Detection in Endometrial Carcinoma
Tingting Chen, MD, Yang Li, MD, Xiao Li, MD, Yanyun Zhang, BMe, Weiguo Lv, MD, Xing Xie, MD, Xiaofei Zhang, MD, Xinyu Wang, MD
Navigating Next-Generation Sequencing Laboratory Developed Tests: A Critical Look at Proficiency Testing, US Food and Drug Administration Regulations, and Clinical Laboratory Performance
Shuko Harada, MD, Alexander C. Mackinnon, MD, PhD